Surgepays (NASDAQ:SURG) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.16) by 331.25 percent. This is a 32.35 percent increase over losses of $(1.02) per share from the same period last year. The company reported quarterly sales of $16.187 million which missed the analyst consensus estimate of $21.157 million by 23.49 percent. This is a 68.67 percent increase over sales of $9.597 million the same period last year.